Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

New England Journal of Medicine

Volumn 340, Issue 25, 1999, Pages 1954-1961

  Bown, Nick ^a   Cotterill, Simon ^a   Łastowska, Maria ^a   O'Neill, Seamus ^a   Pearson, Andrew D J ^a   Plantaz, Dominique ^b   Meddeb, Mounira ^c   Danglot, Gisele ^c   Brinkschmidt, Christian ^d   Christiansen, Holger ^e   Laureys, Genevieve ^f   Speleman, Frank ^f   Nicholson, James ^g   Bernheim, Alien ^c   Betts, David R ^h   Vandesomple, Jo ^f   Van Roy, Nadine ^f  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 17Q; CLINICAL TRIAL; CYTOGENETICS; GENE DELETION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROBLASTOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ANALYSIS OF VARIANCE; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 17; GENE AMPLIFICATION; GENES, MYC; HUMANS; INFANT; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL RATE; TRANSLOCATION, GENETIC;

EID: 0033600283     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199906243402504     Document Type: Article

References (28)

1. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 1997;19:93-101.
2. Ambros IM, Zellner A, Roald B, et al. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 1996;334:1505-11.
3. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
4. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993;328:847-54.
5. Biedler JL, Ross RA, Shanske S, Spengler BA. Human neuroblastoma cytogenetics: search for significance of homogeneously staining regions and double minute chromosomes. In: Evan AE, ed. Advances in neuroblastoma research. New York: Raven Press, 1980:81-96.
6. Gilbert F, Feder M, Balaban G, et al. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 1984;44:5444-9.
7. Savelyeva L, Corvi R, Schwab M. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 1994;55:334-40.
8. Van Roy N, Laureys G, Cheng NC, et al. 1;17 Translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 1994;10:103-14.
9. Meddeb M, Danglot G, Chudoba I, et al. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Genes Chromosomes Cancer 1996;17:156-65.
10. Brinkschmidt C, Christiansen H, Terpe HJ, et al. Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in paediatric tumour pathology. J Pathol 1997; 181:394-400.
11. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 1997;150:81-9.
12. Łastowska M, Nacheva E, McGuckin A, et al. Comparative genomic hybridization study of primary neuroblastoma tumors. Genes Chromosomes Cancer 1997;18:162-9.
13. Van Gele M, Van Roy N, Jauch A, et al. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis. Eur J Cancer 1997;33:1979-82.
14. Vandesompele J, Van Roy N, Van Gele M, et al. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 1998;23:141-52.
15. Łastowska M, Roberts P, Pearson ADJ, Lewis I, Wolstenholme J, Bown N. Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosomes Cancer 1997;19:143-9.
16. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995;24:215-21.
17. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996;334:225-30.
18. Łastowski M, Cotterill S, Pearson ADJ, et al. Gain of chromosome arm 17q predicts unfavorable outcome in neuroblastoma patients. Eur J Cancer 1997;33:1627-33.
19. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77.
20. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993;90:590-610.
21. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
22. Strehl S, Ambros PF. Fluorescence in situ hybridization combined with immunohistochemistry for highly sensitive detection of chromosome 1 aberrations in neuroblastoma. Cytogenet Cell Genet 1993;63:24-8.
23. Peter M, Michon J, Vielh P, et al. PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int J Cancer 1992;52:544-8.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
25. Bernstein ML, Leclerc JM, Bunin G, et al. A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol 1992;10:323-9. [Erratum, J Clin Oncol 1992;10:1202.]
26. Łastowska M, Van Roy N, Bown N, et al. Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines. Genes Chromosomes Cancer 1998;23:116-22.
27. Matthay KK. Stage 4S neuroblastoma: what makes it special? J Clin Oncol 1998;16:2003-6.
28. Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the Pediatric Oncology Group experience - a Pediatric Oncology Group study. J Clin Oncol 1998;16:2007-17.